{
    "hands_on_practices": [
        {
            "introduction": "The initial evaluation of a patient with suspected biliary pathology hinges on the correct interpretation of liver function tests. This exercise challenges you to analyze a classic biochemical profile to distinguish between a cholestatic and a hepatocellular injury pattern, a fundamental skill for guiding further diagnostic workup. By correctly identifying the pattern of extrahepatic obstruction in this scenario , you will reinforce the critical reasoning that links biochemical data to the underlying pathophysiology of a choledochal cyst.",
            "id": "5096027",
            "problem": "A $26$-year-old woman presents with episodic right upper quadrant pain, pruritus, and jaundice. Prior ultrasonography performed at an outside clinic reported fusiform dilation of the extrahepatic bile duct without gallstones, raising suspicion for a Type I choledochal cyst. On examination, she is afebrile and hemodynamically stable, without peritoneal signs. Laboratory studies show aspartate aminotransferase (AST) $75$ units per liter, alanine aminotransferase (ALT) $82$ units per liter, alkaline phosphatase (ALP) $750$ units per liter, gamma-glutamyl transferase (GGT) $900$ units per liter, total bilirubin $6.5$ milligrams per deciliter, and direct (conjugated) bilirubin $4.8$ milligrams per deciliter. Based on fundamental definitions distinguishing hepatocellular injury from cholestasis and the pathophysiology of extrahepatic biliary obstruction, which option best interprets this biochemical pattern and aligns with an appropriate next step in management for a suspected Type I choledochal cyst?\n\nA. The laboratory profile indicates a predominantly hepatocellular injury pattern consistent with acute viral hepatitis; the appropriate next step is percutaneous liver biopsy to confirm etiology before any biliary imaging.\n\nB. The laboratory profile indicates a predominantly cholestatic, conjugated hyperbilirubinemia pattern consistent with extrahepatic biliary obstruction; the appropriate next step is noninvasive ductal mapping with magnetic resonance cholangiopancreatography followed by definitive extrahepatic cyst excision and Roux-en-Y hepaticojejunostomy after clinical optimization.\n\nC. The laboratory profile indicates isolated hemolysis with unconjugated hyperbilirubinemia; conservative management with observation is appropriate as no biliary intervention is indicated.\n\nD. The laboratory profile indicates intrahepatic cholestasis without extrahepatic obstruction; definitive management is internal drainage of the cyst into the duodenum (cyst-enterostomy) without cyst excision.\n\nE. The laboratory profile suggests pancreatitis-related hepatocellular injury; endoscopic sphincterotomy is indicated as the primary therapeutic step rather than surgical resection.",
            "solution": "The problem statement is first subjected to a rigorous validation process.\n\n### Step 1: Extract Givens\n- **Patient Demographics:** A $26$-year-old woman.\n- **Clinical Presentation:** Episodic right upper quadrant pain, pruritus, and jaundice.\n- **Prior Imaging:** Ultrasonography showing fusiform dilation of the extrahepatic bile duct without gallstones.\n- **Suspected Diagnosis:** Type I choledochal cyst.\n- **Physical Examination:** Afebrile, hemodynamically stable, no peritoneal signs.\n- **Laboratory Data:**\n    - Aspartate aminotransferase (AST): $75$ units/liter\n    - Alanine aminotransferase (ALT): $82$ units/liter\n    - Alkaline phosphatase (ALP): $750$ units/liter\n    - Gamma-glutamyl transferase (GGT): $900$ units/liter\n    - Total bilirubin: $6.5$ milligrams/deciliter (mg/dL)\n    - Direct (conjugated) bilirubin: $4.8$ mg/dL\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for scientific validity, posing, and objectivity.\n\n- **Scientific Grounding:** The problem is scientifically grounded. The clinical vignette describes a classic presentation of a Type I choledochal cyst. The symptoms of biliary obstruction (pain, jaundice, pruritus), the ultrasound findings, and the laboratory values are all internally consistent and plausible within the context of hepatobiliary pathophysiology and surgery.\n- **Well-Posedness:** The problem is well-posed. It provides sufficient clinical and biochemical data to allow for a differential analysis of liver injury patterns and to determine the standard-of-care management pathway. The question asks for an interpretation and a next step, for which a logical, unique answer can be derived.\n- **Objectivity:** The problem is stated in objective, clinical language, free from ambiguity or subjective claims.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. It is a standard clinical reasoning problem that is scientifically sound, well-posed, and objective. The solution process may proceed.\n\n### Derivation of Solution\nThe solution requires a two-part analysis: first, interpreting the provided biochemical profile based on fundamental principles of liver function tests; and second, determining the appropriate management strategy for the suspected diagnosis based on modern surgical standards.\n\n**1. Interpretation of the Biochemical Profile**\n\nThe standard approach to interpreting liver function tests involves categorizing them into patterns of hepatocellular injury versus cholestasis.\n\n- **Markers of Hepatocellular Injury:** These are the transaminases, AST and ALT. In this case, AST is $75$ U/L and ALT is $82$ U/L. Normal values are typically below approximately $40$ U/L. These values represent a mild elevation, typically less than $2$-$3$ times the upper limit of normal. This mild elevation is insufficient to characterize the primary process as hepatocellular. A predominantly hepatocellular injury pattern (e.g., from viral hepatitis, ischemia, or drug toxicity) would feature AST and ALT elevations in the high hundreds to thousands.\n\n- **Markers of Cholestasis:** These are ALP and GGT. In this case, ALP is $750$ U/L (normal < ~$120$ U/L) and GGT is $900$ U/L (normal < ~$60$ U/L). Both markers are markedly elevated, approximately $6$-$7$ times the upper limit of normal for ALP and over $15$ times for GGT. The concordant, significant elevation of GGT confirms the hepatic origin of the elevated ALP (ruling out bone or other sources) and firmly establishes a **cholestatic pattern** of liver injury.\n\n- **Bilirubin Analysis:** Jaundice is clinically present and confirmed by a total bilirubin of $6.5$ mg/dL. We must determine if this is a conjugated or unconjugated hyperbilirubinemia. The direct (conjugated) bilirubin is $4.8$ mg/dL. The fraction of direct bilirubin is calculated as:\n$$ \\frac{\\text{Direct Bilirubin}}{\\text{Total Bilirubin}} = \\frac{4.8 \\, \\text{mg/dL}}{6.5 \\, \\text{mg/dL}} \\approx 0.738 $$\nSince this fraction ($73.8\\%$) is greater than $20\\%$, and certainly greater than $50\\%$, this is a **conjugated hyperbilirubinemia**. Conjugated hyperbilirubinemia results from impaired excretion of bilirubin from the hepatocyte into the bile canaliculus (intrahepatic cholestasis) or obstruction of bile flow downstream in the biliary tree (extrahepatic cholestasis).\n\n- **Synthesis:** The combination of markedly elevated ALP and GGT with only mildly elevated AST/ALT, along with a conjugated hyperbilirubinemia, is the classic biochemical signature of **obstructive cholestasis**. Given the ultrasound finding of a dilated extrahepatic bile duct, the obstruction is localized to the extrahepatic biliary system. This entire profile is perfectly explained by the pathophysiology of a Type I choledochal cyst, where the cystic dilation impedes bile flow, leading to stasis and obstruction.\n\n**2. Determination of Appropriate Management**\n\n- **Diagnostic Confirmation and Preoperative Planning:** The initial ultrasound is suggestive but not definitive for anatomical characterization. Before proceeding with major surgery, high-resolution, non-invasive imaging of the entire biliary tree and pancreaticobiliary junction is mandatory. **Magnetic Resonance Cholangiopancreatography (MRCP)** is the gold standard for this purpose. It precisely defines the cyst's anatomy (Todani classification), delineates its relationship with the pancreatic duct (important for assessing for an anomalous pancreaticobiliary junction, a common associated finding), and assesses for any concomitant abnormalities or signs of malignancy.\n\n- **Definitive Surgical Management:** A symptomatic choledochal cyst requires definitive surgical treatment. The primary goals are to relieve the biliary obstruction, alleviate symptoms, and, most critically, to remove the tissue at risk for malignant transformation into cholangiocarcinoma. The standard-of-care surgical procedure for a Type I choledochal cyst is **complete excision of the extrahepatic cyst** followed by restoration of biliary-enteric continuity. The reconstruction is most commonly and safely performed via a **Roux-en-Y hepaticojejunostomy**. The patient is clinically stable, so this procedure would be planned electively after appropriate preoperative workup and optimization are complete.\n\n### Evaluation of Options\n\n- **Option A:** The laboratory profile indicates a predominantly hepatocellular injury pattern consistent with acute viral hepatitis; the appropriate next step is percutaneous liver biopsy to confirm etiology before any biliary imaging.\n    - **Evaluation:** The biochemical interpretation is incorrect. As derived above, the pattern is overwhelmingly cholestatic, not hepatocellular. Consequently, the proposed next step of a liver biopsy is inappropriate; the primary pathology is in the bile ducts, which must be imaged.\n    - **Verdict:** Incorrect.\n\n- **Option B:** The laboratory profile indicates a predominantly cholestatic, conjugated hyperbilirubinemia pattern consistent with extrahepatic biliary obstruction; the appropriate next step is noninvasive ductal mapping with magnetic resonance cholangiopancreatography followed by definitive extrahepatic cyst excision and Roux-en-Y hepaticojejunostomy after clinical optimization.\n    - **Evaluation:** This option is entirely correct. It accurately identifies the cholestatic pattern and conjugated hyperbilirubinemia of extrahepatic obstruction. It also correctly outlines the standard modern management pathway: MRCP for diagnostic mapping followed by cyst excision with Roux-en-Y hepaticojejunostomy as the definitive cure.\n    - **Verdict:** Correct.\n\n- **Option C:** The laboratory profile indicates isolated hemolysis with unconjugated hyperbilirubinemia; conservative management with observation is appropriate as no biliary intervention is indicated.\n    - **Evaluation:** The biochemical interpretation is incorrect. The hyperbilirubinemia is predominantly conjugated, not unconjugated. Hemolysis would not cause the profound elevation in ALP and GGT. Furthermore, conservative management is contraindicated for a symptomatic choledochal cyst due to risks of cholangitis, pancreatitis, and malignancy.\n    - **Verdict:** Incorrect.\n\n- **Option D:** The laboratory profile indicates intrahepatic cholestasis without extrahepatic obstruction; definitive management is internal drainage of the cyst into the duodenum (cyst-enterostomy) without cyst excision.\n    - **Evaluation:** The localization of cholestasis is incorrect; ultrasound evidence points to an extrahepatic cause. More importantly, the proposed management (cyst-enterostomy) is an obsolete and dangerous procedure. It fails to resect the premalignant tissue of the cyst wall and is associated with high rates of recurrent cholangitis (\"sump syndrome\") and subsequent cancer.\n    - **Verdict:** Incorrect.\n\n- **Option E:** The laboratory profile suggests pancreatitis-related hepatocellular injury; endoscopic sphincterotomy is indicated as the primary therapeutic step rather than surgical resection.\n    - **Evaluation:** The biochemical interpretation is incorrect; the pattern is cholestatic, not hepatocellular, and there is no direct evidence given for pancreatitis. While an endoscopic sphincterotomy may temporarily decompress the biliary system, it is not a definitive treatment. It does not address the cyst itself or its malignant potential. Surgical resection is the required definitive therapy.\n    - **Verdict:** Incorrect.",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "A crucial aspect of evaluating choledochal cysts is identifying an Anomalous Pancreaticobiliary Ductal Junction (APBDJ), as it fundamentally alters pathophysiology and surgical considerations. This problem asks you to synthesize anatomical findings from imaging with specific biochemical data from bile aspirate . By analyzing the stark difference in amylase concentrations between bile and serum, you can deduce the direction of reflux across the common channel and solidify your understanding of how APBDJ contributes to both cyst formation and long-term cancer risk.",
            "id": "5096142",
            "problem": "A patient with a known choledochal cyst presents for evaluation. Magnetic resonance cholangiopancreatography reveals a dilated common channel between the distal common bile duct and the pancreatic duct. Intraoperative bile aspirate from the common hepatic duct demonstrates a bile amylase concentration of $10{,}000 \\,\\mathrm{U/L}$, while concurrent serum amylase is $250 \\,\\mathrm{U/L}$. Using the core definitions of sphincter physiology and ductal anatomy, and the well-established facts that pancreatic juice normally contains amylase at concentrations orders of magnitude higher than those found in bile or serum, and that flow across a junction follows prevailing pressure gradients, reason about the directionality of reflux across a long common channel and the likelihood of an Anomalous Pancreaticobiliary Ductal Junction (APBDJ). Choose the single best inference.\n\nOptions:\nA. The findings indicate pancreatic-to-biliary reflux through the long common channel, making Anomalous Pancreaticobiliary Ductal Junction (APBDJ) highly likely.\n\nB. The findings indicate biliary-to-pancreatic reflux causing the elevated serum amylase, so APBDJ is unlikely.\n\nC. Pancreatic-to-biliary reflux is present, but APBDJ is unlikely because elevated bile amylase is nonspecific in obstructive jaundice.\n\nD. There is no reflux; the high bile amylase is explained by diffusion from serum, and the presence of APBDJ cannot be inferred.\n\nE. Bidirectional reflux is occurring; APBDJ should be diagnosed only if serum amylase exceeds bile amylase.",
            "solution": "The problem statement is evaluated for validity before proceeding to a solution.\n\n### Step 1: Extract Givens\n- A patient has a known choledochal cyst.\n- Magnetic resonance cholangiopancreatography (MRCP) reveals a dilated common channel between the distal common bile duct and the pancreatic duct.\n- Intraoperative bile aspirate from the common hepatic duct shows a bile amylase concentration of $10,000 \\,\\mathrm{U/L}$.\n- Concurrent serum amylase is $250 \\,\\mathrm{U/L}$.\n- A core fact is that pancreatic juice normally contains amylase at concentrations orders of magnitude higher than those in bile or serum.\n- A core principle is that flow across a junction follows prevailing pressure gradients.\n- The task is to reason about the directionality of reflux and the likelihood of an Anomalous Pancreaticobiliary Ductal Junction (APBDJ).\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem is grounded in established principles of hepatobiliary anatomy, physiology, and pathology. The concepts of APBDJ, choledochal cysts, sphincter of Oddi function, pressure gradients, and amylase as a diagnostic marker are fundamental in gastroenterology and surgery. The provided laboratory values are clinically plausible for the described scenario.\n- **Well-Posed:** The problem is well-posed. It provides specific anatomical (MRCP findings) and biochemical (amylase concentrations) data and asks for a logical inference based on stated physiological principles. A unique and meaningful conclusion can be derived.\n- **Objective:** The language is objective and clinical, presenting factual findings without subjective interpretation.\n\n### Step 3: Verdict and Action\nThe problem statement is scientifically sound, well-posed, and objective. It contains sufficient, consistent information to derive a logical conclusion. Therefore, the problem is **valid**. A solution will be derived.\n\n### Derivation\nThe problem requires an inference based on anatomical and biochemical data, guided by principles of fluid dynamics and physiology.\n\n1.  **Anatomical Consideration:** The MRCP finding of a \"dilated common channel between the distal common bile duct and the pancreatic duct\" is the defining anatomical feature of an Anomalous Pancreaticobiliary Ductal Junction (APBDJ). In normal anatomy, the common bile duct and pancreatic duct join at the ampulla of Vater within the duodenal wall and are controlled by the sphincter of Oddi. In APBDJ, this junction occurs proximally, outside the duodenal wall, forming a \"long common channel\" that is not under the influence of the sphincter. This anatomical arrangement predisposes the two ductal systems to free communication.\n\n2.  **Biochemical and Physiological Analysis:**\n    - The concentration of amylase in the aspirated bile is given as $10,000 \\,\\mathrm{U/L}$. Normal bile contains negligible to no amylase. This value is exceptionally high.\n    - The concurrent serum amylase is $250 \\,\\mathrm{U/L}$. While elevated above the typical normal range (which is generally below $\\approx 150 \\,\\mathrm{U/L}$), this value is $40$ times lower than the concentration found in the bile.\n    - A fundamental principle provided is that pancreatic juice is the body's primary source of high-concentration amylase, with levels several orders of magnitude higher than in serum or normal bile.\n\n3.  **Inference of Reflux Direction:** Material transport, including solute diffusion and bulk fluid flow, occurs along gradients.\n    - **Diffusion/Transport Gradient:** For amylase to move from serum into bile, the serum concentration would need to be higher than the bile concentration. Here, the bile concentration ($10,000 \\,\\mathrm{U/L}$) is vastly higher than the serum concentration ($250 \\,\\mathrm{U/L}$). Therefore, movement of amylase from serum to bile is thermodynamically and physiologically impossible under these conditions.\n    - **Source of High Bile Amylase:** The only plausible source for the extremely high concentration of amylase in the bile is direct admixture with pancreatic juice.\n    - **Direction of Flow:** For pancreatic juice to enter the biliary tree, fluid must flow from the pancreatic duct into the common bile duct. This phenomenon is known as pancreatic-to-biliary reflux. This reflux is facilitated by the APBDJ anatomy, which creates a common channel where pressure dynamics can drive pancreatic juice into the biliary system, especially when the pancreatic duct pressure exceeds the bile duct pressure.\n\n4.  **Synthesis:** The anatomical finding of a long common channel (APBDJ) provides the pathway for reflux. The biochemical finding of extremely high bile amylase confirms that pancreatic juice is indeed refluxing into the biliary system (pancreatic-to-biliary reflux). The presence of a choledochal cyst is also strongly associated with APBDJ, as the refluxed pancreatic enzymes are thought to cause chronic inflammation and weakening of the bile duct wall, leading to cystic dilatation. Therefore, the combination of findings makes the diagnosis of APBDJ with pancreatic-to-biliary reflux a virtual certainty.\n\n### Evaluation of Options\n\n**A. The findings indicate pancreatic-to-biliary reflux through the long common channel, making Anomalous Pancreaticobiliary Ductal Junction (APBDJ) highly likely.**\nThis conclusion is fully supported by the derivation. The high bile amylase ($10,000 \\,\\mathrm{U/L}$) is a direct consequence of pancreatic juice (the high-amylase source) entering the bile duct. This flow constitutes pancreatic-to-biliary reflux. The anatomical substrate for this reflux is the long common channel, which is the definition of APBDJ.\n**Verdict: Correct**\n\n**B. The findings indicate biliary-to-pancreatic reflux causing the elevated serum amylase, so APBDJ is unlikely.**\nThis option mistakes the direction of reflux. Biliary-to-pancreatic reflux (bile into the pancreas) can cause pancreatitis and elevate serum amylase, but it cannot explain the extremely high amylase concentration *within the bile itself*. The primary evidence points to pancreatic-to-biliary reflux. Furthermore, the statement that APBDJ is unlikely contradicts the explicit MRCP finding of a long common channel.\n**Verdict: Incorrect**\n\n**C. Pancreatic-to-biliary reflux is present, but APBDJ is unlikely because elevated bile amylase is nonspecific in obstructive jaundice.**\nThis option correctly identifies pancreatic-to-biliary reflux but incorrectly dismisses its significance and the anatomical evidence. While minor elevations of bile amylase might occur in other conditions, a concentration of $10,000 \\,\\mathrm{U/L}$ is profoundly abnormal and highly specific for admixture with pancreatic juice. Most importantly, concluding APBDJ is \"unlikely\" is in direct contradiction to the given MRCP finding of a \"dilated common channel.\"\n**Verdict: Incorrect**\n\n**D. There is no reflux; the high bile amylase is explained by diffusion from serum, and the presence of APBDJ cannot be inferred.**\nThis is incorrect on two fundamental counts. First, as analyzed above, diffusion from serum is impossible because the concentration gradient is in the opposite direction (bile amylase concentration $\\gg$ serum amylase concentration). Second, the statement that APBDJ cannot be inferred is false; it was directly visualized on MRCP as a \"dilated common channel.\"\n**Verdict: Incorrect**\n\n**E. Bidirectional reflux is occurring; APBDJ should be diagnosed only if serum amylase exceeds bile amylase.**\nThe diagnostic criterion proposed is nonsensical. In APBDJ, the pathophysiology involves pancreatic juice contaminating the bile, so bile amylase concentration is expected to be far higher than serum amylase. A scenario where serum amylase exceeds bile amylase is inconsistent with the known mechanism. The diagnosis of APBDJ is primarily anatomical, corroborated by the high bile amylase, not based on this inverted and arbitrary biochemical relationship.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Optimizing a patient's nutritional status is a cornerstone of modern perioperative care, especially for infants with cholestasis-induced malabsorption. This practice problem focuses on the quantitative skills needed to translate metabolic requirements into a practical feeding regimen . You will apply first principles of energy balance to calculate the correct continuous infusion rate for a specialized enteral formula, a critical step in mitigating malnutrition and preparing the patient for definitive surgical correction.",
            "id": "5096092",
            "problem": "An infant with a Type I choledochal cyst has obstructive cholestasis. Preoperative optimization aims to mitigate malnutrition resulting from impaired bile acid-mediated micellar solubilization of long-chain triglycerides and fat-soluble vitamins. You plan enteral nutrition via a nasogastric tube using a medium-chain triglyceride (MCT)-enriched formula with reduced long-chain triglyceride content and water-miscible vitamins A, D, E, and K (ADEK). To reduce aspiration risk and improve tolerance, you will deliver feeds continuously over $20$ hours per day. For cholestasis in this context, a commonly used preoperative energy goal is $120$ kilocalories per kilogram per day, and the selected MCT-enriched formula is formulated to an energy density of $0.8$ kilocalories per milliliter. The infant weighs $9$ kilograms.\n\nUsing first principles of energy balance, derive an expression for the continuous infusion rate that meets the preoperative energy target and compute its value. Round your final numeric answer to three significant figures. Express the final infusion rate in mL/h.",
            "solution": "The problem statement is evaluated as scientifically grounded, well-posed, objective, and self-contained. The clinical context is realistic, and the provided data are plausible and sufficient for a unique solution. The problem requires the application of first principles of energy balance and rate calculation, representing a valid quantitative task.\n\nThe objective is to derive an expression for the continuous infusion rate, $R$, in units of milliliters per hour ($\\text{mL/h}$), and then compute its numerical value based on the provided data.\n\nThe givens are:\n- Preoperative energy goal, $E_{goal} = 120 \\, \\text{kcal/kg/day}$\n- Infant's mass, $m = 9 \\, \\text{kg}$\n- Energy density of the formula, $\\rho_E = 0.8 \\, \\text{kcal/mL}$\n- Total duration of continuous feeding per day, $T = 20 \\, \\text{h/day}$\n\nThe derivation proceeds in three steps based on first principles.\n\nFirst, we determine the infant's total daily energy requirement, denoted as $E_{total}$. This is the product of the infant's mass and the specific energy goal per unit mass.\n$$\nE_{total} = m \\times E_{goal}\n$$\nSubstituting the given values:\n$$\nE_{total} = (9 \\, \\text{kg}) \\times (120 \\, \\frac{\\text{kcal}}{\\text{kg} \\cdot \\text{day}}) = 1080 \\, \\frac{\\text{kcal}}{\\text{day}}\n$$\n\nSecond, we calculate the total volume of formula, $V_{total}$, required to deliver this amount of energy. The total volume is the total energy requirement divided by the energy density of the formula.\n$$\nV_{total} = \\frac{E_{total}}{\\rho_E}\n$$\nSubstituting the calculated value for $E_{total}$ and the given value for $\\rho_E$:\n$$\nV_{total} = \\frac{1080 \\, \\text{kcal/day}}{0.8 \\, \\text{kcal/mL}} = 1350 \\, \\frac{\\text{mL}}{\\text{day}}\n$$\n\nThird, we derive the expression for the continuous infusion rate, $R$. The rate is the total volume to be administered divided by the total time over which it is administered.\n$$\nR = \\frac{V_{total}}{T}\n$$\nBy substituting the expressions for $V_{total}$ and $E_{total}$ from the previous steps, we can derive a single expression for $R$ in terms of the primary variables:\n$$\nR = \\frac{V_{total}}{T} = \\frac{(E_{total}/\\rho_E)}{T} = \\frac{(m \\times E_{goal})/\\rho_E}{T}\n$$\nThis simplifies to the general expression for the infusion rate:\n$$\nR = \\frac{m \\times E_{goal}}{T \\times \\rho_E}\n$$\nThis is the required symbolic expression.\n\nFinally, we compute the numerical value of $R$. We can either use the intermediate value for $V_{total}$ or substitute all givens into the final expression. Using the intermediate value $V_{total} = 1350 \\, \\text{mL/day}$:\n$$\nR = \\frac{1350 \\, \\text{mL/day}}{20 \\, \\text{h/day}}\n$$\nThe unit `day` cancels, leaving the desired unit `mL/h`.\n$$\nR = \\frac{1350}{20} \\, \\frac{\\text{mL}}{\\text{h}} = 67.5 \\, \\frac{\\text{mL}}{\\text{h}}\n$$\nThe problem requires the answer to be rounded to three significant figures. The calculated value $67.5$ already contains exactly three significant figures ($6$, $7$, and $5$). Therefore, no further rounding is necessary.",
            "answer": "$$\\boxed{67.5}$$"
        }
    ]
}